METRO DETROIT'S WINTER WEATHER: ADVISORY | WOMAN FREEZES TO DEATH TRAFFIC | FORECAST |

Allegan

perrigo

Perrigo Reports Record Revenue; Acquisition Charges Ding Profits

The generic drug and store brand health products maker Perrigo Co. (Nasdaq: PRGO) Wednesday reported record revenue of $919.8 million in the third fiscal quarer ended March 30, up from $778 million a year earlier.

WWJ Newsradio 950–05/08/2013

Photo courtesy Michigan Humane Society.

Perrigo Closes Acquisition Of Pet Health Company Velcera

Perrigo Co. (Nasdaq: PRGO) Monday announced that it has closed the acquisition of Velcera Inc., the Yardley, Pa.-based pet health products company, for $160 million in cash.

WWJ Newsradio 950–04/01/2013

perrigo

Perrigo Starting Shipments of Guaifenesin Extended-Release 600mg

Perrigo Co. (Nasdaq: PRGO) Monday announced that it has begun shipments of Guaifenesin 600mg Extended-Release tablets in a launch to its retail and wholesale customers

WWJ Newsradio 950–03/18/2013

perrigo

Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%

Perrigo Co. (Nasdaq: PRGO) announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for testosterone gel 1.62 percent and that it has notified AbbVie Inc., the owner of the Reference Listed Drug of its filing.

WWJ Newsradio 950–02/19/2013

perrigo

Perrigo Confirms FDA Approval For Testosterone Gel 1%

Perrigo Company (Nasdaq: PRGO) announced that it has received U.S. Food and Drug Administration approval for its New Drug Application for testosterone gel 1%. Perrigo’s NDA included a bioequivalence study that compared its product to AbbVie’s AndroGel 1%.

WWJ Newsradio 950–02/06/2013

perrigo

Perrigo Reports Record Second Quarter Revenue, Higher Profit

The Allegan generic drugmaker Perrigo Co. Friday record revenue of $883 million for its second fiscal quarter ended Dec. 29, up from $838.2 million in the same quarter a year earlier. Net income for the quarter was $106 million or $1.12 a share, up from $99.7 million or $1.06 aa share in the same quarter a year earlier.

WWJ Newsradio 950–02/03/2013

perrigologo

Perrigo Announces Quarterly Dividend

Perrigo Co. (Nasdaq: PRGO) Thursday announced that its board of directors declared a quarterly dividend of 9 cents a share.

WWJ Newsradio 950–01/31/2013

perrigo

Perrigo Offers New Packaging For Infant Formula

Allegan’s Perrigo Co., the world’s largest makers of store brand infant formulas, Friday announced a new packaging look with new features.

WWJ Newsradio 950–01/27/2013

perrigo

Perrigo Launches Store Brand Version Of Nicorette Mini Nicotine Lozenges

The Perrigo Company (Nasdaq: PRGO) announced that it has begun shipments of over-the-counter nicotine polacrilex mini lozenge USP, 2 mg (mint flavor) and 4 mg (mint flavor).

WWJ Newsradio 950–01/22/2013

perrigo

Perrigo Announces Commercial Launch Of Betamethasone Foam

Perrigo Co. Tuesday announced that it has begun commercial shipments of betamethasone valerate foam 0.12%, the generic equivalent of Luxiq Foam, consistent with the date certain launch settlement previously announced.

WWJ Newsradio 950–01/15/2013

more

previous

Follow

Get every new post delivered to your Inbox.

Join 2,046 other followers